Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000096

Director acquired 5,986 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tessier-Lavigne Marc · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-02 Grant or award : show line 1 in the form +5,986 2,030,356 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-02 Grant or award : show line 2 in the form Stock Option (right to buy) +17,959 17,959 D
Loading xslF345X03/wf-form4_165456054624289.xml…